Australia is carefully awaiting the arrival of retatrutide, a novel dual GIP and GLP-1 receptor agonist that's generating significant buzz in the global weight management landscape. Developed by Novo Nordisk, this https://laytnxurv240190.wikifordummies.com/9797986/novo_nordisk_s_retatrutide_australia_a_promising_solution_for_weight_management